Three studies examining variable cohort sizes (n = 54–350) of American or Asian populations found no difference in myopia (not inclusive of severe myopia) incidence amongst the anti-VEGF or laser-treated groups after approximately 3 to 9 years of follow-up [24,34,36]. The gene discussed is VEGFA; the disease is myopia.